Company news
Diamyd Medical Ab Class B (OMXSTO:DMYD_B) news
Every Diamyd Medical Ab Class B press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Diamyd Medical enters into equity financing agreements with new U.S. sector specialist investors for up to USD 125 million and announces ...
March 23, 2026
Diamyd Medical announces finalization of database for interim analysis in Phase 3 DIAGNODE-3 trial
February 24, 2026
Diamyd Medical receives Notice of Allowance for key retogatein US patent
February 9, 2026
Diamyd Medical accelerates primary efficacy readout by 9 months in type 1 diabetes Phase 3 trial following FDA alignment and guidance
December 29, 2025